ClinicalTrials.gov
ClinicalTrials.gov Menu

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00118196
Recruitment Status : Terminated (Due to limited resources available to conduct study)
First Posted : July 11, 2005
Last Update Posted : May 11, 2018
Sponsor:
Information provided by (Responsible Party):
Medical University of South Carolina

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 11, 2006
  Actual Study Completion Date : August 11, 2006